LARS1 and cancer: Thus, while under physiological conditions the regulatory effect of CLRs on innate immunity cells is finalized to the preservation of homeostasis, in pathological conditions such as cancer, CLR activity may hamper the activation of a protective immune response and actually favour tumor spread.